Clinical practice in vesicoureteral reflux with respect to EAU guidelines: A multicenter study.


Journal

International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 09 12 2020
accepted: 04 05 2021
pubmed: 10 5 2021
medline: 24 7 2021
entrez: 9 5 2021
Statut: ppublish

Résumé

We designed a multicenter, retrospective study to investigate the current trends in initial management of reflux with respect to European Association of Urology (EAU) Guidelines in Urology clinics of our country. The study group consisted of 1988 renal units (RU) of 1345 patients treated surgically due to vesicoureteral reflux (VUR) (between years 2003 and 2017) in nine different institutions. Patients were divided into two groups according to time of initial treatment and also grouped according to risk factors by "EAU guidelines on VUR." In this series, 1426 RUs were treated initially conservatively and 562 RUs were initially treated with surgery. In initially surgically treated group, success rates of surgery decreased significantly in low and moderate risk groups after 2013 (P = .046, P = .0001, respectively), while success rates were not significantly different in high risk group (P = .46). While 26.6% of patients in low risk group were initially surgically treated before 2013, this rate has increased to 34.6% after 2013, but the difference was not statistically significant (P = .096). However, performing surgery as the initial treatment approach increased significantly in both moderate and high risk groups (P = .000 and P = .0001, respectively) after 2013. Overall success rates of endoscopic treatments and ureteroneocystostomy (UNC) operations were 65% and 92.9% before 2013 and 60% and 78.5% after 2013, respectively. Thus, the overall success rate for surgery was 72.6%. There was significant difference between success rates of UNC operations before and after 2013 (P = .000), while the difference was not significant in the injection group (P = .076). Current trends in management of reflux in our country do not yet follow the EAU guidelines on VUR in low and moderate risk groups despite these reliable and accepted guidelines were expected to influence our daily approach.

Identifiants

pubmed: 33966353
doi: 10.1111/ijcp.14339
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14339

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Slabbaert K, Bogaert G. Vesicoureteric reflux (VUR) in children: where are we now. Arch Esp Urol. 2012;65:450-458.
Sargent M. Opinion: what is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30:587-593.
Caillaud C, Lacreuse I, Fothergill H, et al. Observational, medical or surgical management of vesicoureteric reflux. Acta Paediatr. 2013;102:222-225.
Cooper CS, Austin JC. Vesicoureteral reflux: who benefits from surgery? Urol Clin North Am. 2004;31:535-541.
Sillén U, Brandström P, Jodal U, et al. The Swedish reflux trial in children: v. Bladder dysfunction. J Urol. 2010;184:298-304.
Tekgül S, Riedmiller H, Hoebeke P, et al. EAU guidelines on vesicoureteral reflux in children. Eur Urol. 2012;62:534-542.
Peters CA, Skoog SJ, Arant BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184:1134-1144.
Routh JC, Bogaert GA, Kaefer M, et al. Vesicoureteral reflux: current trends in diagnosis, screening, and treatment. Eur Urol. 2012;61:773-782.
Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009;361:1748-1759.
Brandström P, Jodal U, Sillén U, Hansson S. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Pediatr Urol. 2011;7:594-600.
Hellerstein S, Nickell E. Prophylactic antibiotics in children at risk for urinary tract infection. Pediatr Nephrol. 2002;17:506-510.
Weiss R, Duckett J, Spitzer A. Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). J Urol. 1992;148:1667-1673.
Group BRS. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Br Med J (Clin Res Ed). 1987;295:237-241.
Investigators RT. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370:2367-2376.
Thompson RH, Chen JJ, Pugach J, et al. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol. 2001;166:1465-1469.
Garin EH, Olavarria F, Nieto VG, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117:626-632.
Pennesi M, Travan L, Peratoner L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121:e1489-e1494.
Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674-679.
Prisca RA, Gozar H, Prisca AM, et al. Parent compliance: a bad predictor of resolution and a problem in the application of EAU guidelines on vesicoureteral reflux in children. Int Urol Nephrol. 2017;49:741-745.
Johnin K, Kobayashi K, Tsuru T, et al. Pediatric voiding cystourethrography: an essential examination for urologists but a terrible experience for children. Int J Urol. 2019;26:160-171.
Bisignani G, Decter RM. Voiding cystourethrography after uncomplicated ureteral reimplantation in children: is it necessary? J Urol. 1997;158:1229-1231.
Läckgren G, Cooper CS, Neveus T, Kirsch AJ. Management of vesicoureteral reflux: what have we learned over the last 20 years? Frontiers. Front Pediatr. 2021;9:650326.
Falkensammer ML, Gobet R, Stauffer UG, Weber DM. To cohen and forget? Evaluation of postoperative imaging studies after transtrigonal ureteric reimplantation for vesicoureteric reflux in children. Urol Int. 2008;81:218-221.
Grossklaus DJ, Pope JC IV, Adams MC, Brock JW III. Is postoperative cystography necessary after ureteral reimplantation? Urology. 2001;58:1041-1044.

Auteurs

Eda Tokat (E)

Department of Urology, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey.

Serhat Gurocak (S)

Department of Pediatric Urology, Gazi University School of Medicine, Ankara, Turkey.

Secil Ozkan (S)

Department of Public Health, Gazi University School of Medicine, Ankara, Turkey.

Hasan Serkan Dogan (HS)

Department of Pediatric Urology, Hacettepe University School of Medicine, Ankara, Turkey.

Burak Citamak (B)

Department of Pediatric Urology, Hacettepe University School of Medicine, Ankara, Turkey.

Nihat Satar (N)

Department of Urology, Cukurova University School of Medicine, Adana, Turkey.

Volkan Izol (V)

Department of Urology, Cukurova University School of Medicine, Adana, Turkey.

Mutlu Deger (M)

Department of Urology, Cukurova University School of Medicine, Adana, Turkey.

Saban Sarikaya (S)

Department of Urology, Samsun Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Yakup Bostanci (Y)

Department of Urology, Samsun Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Murat Gulsen (M)

Department of Urology, Samsun Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Bulent Onal (B)

Department of Pediatric Urology, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.

Elif Altinay Kirli (E)

Department of Pediatric Urology, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.

Berk Burgu (B)

Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey.

Tarkan Soygur (T)

Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey.

Perviz Haciyev (P)

Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey.

Koray Agras (K)

Department of Pediatric Urology, Gazi University School of Medicine, Ankara, Turkey.

Bilge Karabulut (B)

Department of Pediatric Urology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Trainig and Research Hospital, Ankara, Turkey.

Cem Akbal (C)

Department of Urology, Acıbadem University School of Medicine, Istanbul, Turkey.

Cagri Akin Sekerci (C)

Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.

Deniz Demirci (D)

Department of Urology, Erciyes University School of Medicine, Kayseri, Turkey.

Numan Baydilli (N)

Department of Urology, Erciyes University School of Medicine, Kayseri, Turkey.

Serdar Tekgul (S)

Department of Pediatric Urology, Hacettepe University School of Medicine, Ankara, Turkey.

Mustafa Ozgur Tan (M)

Department of Pediatric Urology, Gazi University School of Medicine, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH